Stem Save Inc is categorized under Commercial Medical Research in New York City, NY and active since 2007.
Stem Save Inc was established in 2007, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Commercial Medical Research business, which does work in the B2B market, and is classified as a Commercial Medical Research, under code number 6219910 by the NAICS.
If you are seeking more information, feel free to contact Arthur E Greco at the company’s single location by writing to 526 West 26th St Room 622, New York City, New York NY 10001 or by phoning (877) 783-6728. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Stem Save Inc |
| Contact Person: | Arthur E Greco |
| Address: | 526 West 26th St Room 622, New York City, New York 10001 |
| Phone Number: | (877) 783-6728 |
| Website Address: | stemsave.com |
| Annual Revenue (USD): | $1.000.000 to $2.499.999 |
| Founded: | 2007 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Commercial Medical Research |
| SIC Code: | 8731 |
| NAICS Code: | 6219910 |
| Share This Business: |
Stem Save Inc was started in 2007 to provide professional Commercial Medical Research under the SIC code 8731 and NAICS code 6219910. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Arthur E Greco for inquiries that concern Stem Save Inc by calling the company number (877) 783-6728, as your correspondence is most welcome. Additionally, the physical location of the single location of Stem Save Inc can be found at the coordinates 40.74988,-74.003612 as well as the street address 526 West 26th St Room 622 in New York City, New York 10001.
For its online presence, you may visit Stem Save Inc’s website at stemsave.com and engage with its social media outlets through on Twitter and on Facebook.